Stay updated on Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now displays a new revision label 'Revision: v3.3.2' and the previous 'Revision: v3.3.1' was removed. This is a minor site maintenance detail and does not affect study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:59:16.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.1, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T13:27:57.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page, which is unrelated to the study details and does not affect the trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:34:17.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The screenshots show only minor administrative updates, such as the last update date, with no changes to the study design, eligibility criteria, outcomes, or listed sites. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:12:57.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    4%
    Check dated 2025-10-05T10:13:45.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:23.000Z thumbnail image

Stay in the know with updates to Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.